Hepatitis B vaccine recombinant (Shantha)

重组乙型肝炎疫苗(Shantha)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis B vaccine recombinant (Shantha)
Drug Alias NameShanvac B
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date1997/01/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesShantha Biotechnics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShantha Biotechnics Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ07BC01
Related LinksN/A